Table 3.
Variable | Patient number | COUP‐TFII labeling index (%) | P‐value | P‐value adjusted by Bonferroni |
---|---|---|---|---|
Menopausal status | ||||
pre‐ | 51 | 24.9 ± 3.4 | ||
post‐ | 68 | 27.5 ± 3.3 | 0.7616 | |
Stage | ||||
I | 32 | 21.9 ± 4.5 | ||
II | 58 | 22.6 ± 3.0 | 0.9071 (I vs II) | |
III | 13 | 26.0 ± 7.6 | 0.6247 (I vs III) | |
IV | 16 | 44.8 ± 7.4 | 0.0037 (I vs IV) | 0.0222 |
Tumor size (cm) | ||||
≥2.5 | 65 | 26.6 ± 3.1 | ||
<2.5 | 54 | 24.8 ± 3.6 | 0.582 | |
Lymph node status | ||||
Positive | 46 | 34.1 ± 4.3 | ||
Negative | 73 | 20.5 ± 2.6 | 0.0369 | |
Histological grade | ||||
1 (well) | 34 | 15.3 ± 3.3 | ||
2 (moderate) | 44 | 28.6 ± 4.0 | 0.0231 (1 vs 2) | 0.0693 |
3 (poor) | 41 | 31.3 ± 4.4 | 0.0074 (1 vs 3) | 0.0222 |
Estrogen receptor α status | ||||
Positive | 83 | 29.8 ± 3.0 | ||
Negative | 36 | 16.5 ± 3.6 | 0.0050 | |
Progesterone receptor status | ||||
Positive | 78 | 26.7 ± 2.9 | ||
Negative | 41 | 24.0 ± 4.2 | 0.2964 | |
Ki‐67 status | ||||
Positive | 72 | 28.8 ± 3.1 | ||
Negative | 47 | 21.1 ± 3.6 | 0.1157 | |
HER2 status | ||||
Positive | 27 | 28.2 ± 5.5 | ||
Negative | 92 | 25.4 ± 2.6 | 0.8364 |
Data are presented as means ± SEM. All other values represent the number of cases. P‐values less than 0.05 were considered significant, and are shown in bold. HER, XXX.